Patton Albertson Miller Group, LLC Abbott Laboratories Transaction History

Patton Albertson Miller Group, LLC

$660 Million
Q1 2025

A detailed history of Patton Albertson Miller Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Patton Albertson Miller Group, LLC holds 12,402 shares of ABT stock, worth $1.66 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

12,402

Previous 12,402 -0.0%

Holding current value

$1.66 Million

Previous $1.65 Million -0.0%

% of portfolio

0.25%

Previous 0.25%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	SELL	$111.1 - $140.22 $57,660 - $72,774	-519 Reduced 4.02%	12,402 $1.65 Million
Q4 2024 Jan 21, 2025	SELL	$111.93 - $119.39 $783 - $835	-7 Reduced 0.05%	12,921 $1.46 Million
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $88,962 - $105,017	889 Added 7.38%	12,928 $1.47 Million
Q2 2024 Aug 02, 2024	BUY	$100.73 - $112.44 $28,808 - $32,157	286 Added 2.43%	12,039 $1.25 Million
Q1 2024 Apr 24, 2024	SELL	$109.52 - $120.96 $34,060 - $37,618	-311 Reduced 2.58%	11,753 $1.34 Million
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $4,960 - $6,072	-55 Reduced 0.45%	12,064 $1.33 Million
Q3 2023 Oct 24, 2023	BUY	$95.53 - $114.62 $131,926 - $158,290	1,381 Added 12.86%	12,119 $1.17 Million
Q2 2023 Jul 13, 2023	SELL	$100.78 - $112.29 $19,248 - $21,447	-191 Reduced 1.75%	10,738 $1.17 Million
Q1 2023 Apr 21, 2023	SELL	$96.86 - $114.01 $41,165 - $48,454	-425 Reduced 3.74%	10,929 $1.11 Million
Q4 2022 Jan 23, 2023	BUY	$95.06 - $111.52 $760 - $892	8 Added 0.07%	11,354 $0
Q3 2022 Oct 13, 2022	BUY	$96.76 - $112.03 $13,256 - $15,348	137 Added 1.22%	11,346 $1.1 Million
Q2 2022 Jul 22, 2022	SELL	$102.07 - $123.37 $25,007 - $30,225	-245 Reduced 2.14%	11,209 $1.22 Million
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $7,297 - $8,898	64 Added 0.56%	11,454 $1.36 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $36,391 - $44,559	315 Added 2.84%	11,390 $1.6 Million
Q3 2021 Oct 27, 2021	BUY	$116.66 - $129.06 $302,732 - $334,910	2,595 Added 30.6%	11,075 $1.31 Million
Q2 2021 Jul 29, 2021	SELL	$105.79 - $124.53 $1,586 - $1,867	-15 Reduced 0.18%	8,480 $983,000
Q1 2021 Apr 21, 2021	SELL	$108.84 - $128.23 $7,074 - $8,334	-65 Reduced 0.76%	8,495 $1.02 Million
Q4 2020 Feb 25, 2021	SELL	$105.0 - $114.42 $420 - $457	-4 Reduced 0.05%	8,560 $1.1 Million
Q3 2020 Nov 03, 2020	SELL	$91.64 - $111.29 $68,730 - $83,467	-750 Reduced 8.05%	8,564 $932,000
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $14,931 - $19,110	-195 Reduced 2.05%	9,314 $852,000
Q1 2020 May 22, 2020	SELL	$62.82 - $91.86 $33,922 - $49,604	-540 Reduced 5.37%	9,509 $750,000
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $3,925 - $4,370	-50 Reduced 0.5%	10,049 $873,000
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $138,473 - $150,148	-1,692 Reduced 14.35%	10,099 $845,000
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $293,123 - $341,870	4,022 Added 51.77%	11,791 $1.02 Million
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $4,304 - $5,203	-65 Reduced 0.83%	7,769 $621,000
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $5,900 - $6,684	-90 Reduced 1.14%	7,834 $576,000
Q3 2018 Oct 25, 2018	SELL	$60.81 - $73.36 $1,824 - $2,200	-30 Reduced 0.38%	7,924 $530,000
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $54,230 - $59,854	-942 Reduced 10.59%	7,954 $485,000
Q1 2018 May 01, 2018	SELL	$56.27 - $63.62 $883,776 - $999,215	-15,706 Reduced 63.84%	8,896 $533,000
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $213,002 - $228,040	-3,968 Reduced 13.89%	24,602 $1.4 Million
Q3 2017 Oct 06, 2017	BUY	$48.06 - $53.64 $1.37 Million - $1.53 Million	28,570	28,570 $1.57 Million

Others Institutions Holding ABT

# of Institutions

3,541

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $234B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patton Albertson Miller Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patton Albertson Miller Group, LLC with notifications on news.

Account

Patton Albertson Miller Group, LLC Abbott Laboratories Transaction History